Skip to main content
TipRanks
Go Ultimate75% OFF

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. (SVE) Cash flow

0 Followers

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. Cash Flow

PL:SVE's free cash flow for Q2 2026 was zł27.00K. For the 2026 fiscal year, PL:SVE's free cash flow was increased by zł65.00K and operating cash flow was zł-38.00K. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
zł 7.22Mzł 13.73Mzł -5.34Mzł 2.95Mzł -3.28M
zł -27.82Mzł -25.89Mzł -72.90Mzł -26.97Mzł -4.49M
zł 21.50Mzł 10.75Mzł 53.33Mzł 36.82Mzł 20.22M
zł 1.67Mzł 760.00Kzł 2.17Mzł 27.09Mzł 14.30M
zł -20.81Mzł -28.11Mzł -117.95Mzł -33.81Mzł -21.71M

Currency in PLN

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. Cash Flow

-100M-75M-50M-25M025M50M75M201720182019202020212022202320242025OperatingInvestingFinancing